BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 7910951)

  • 21. Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects.
    Lacomis D; Giuliani MJ; Van Cott A; Kramer DJ
    Ann Neurol; 1996 Oct; 40(4):645-54. PubMed ID: 8871585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged paralysis in intensive care unit patients after the use of neuromuscular blocking agents: a review of the literature.
    Watling SM; Dasta JF
    Crit Care Med; 1994 May; 22(5):884-93. PubMed ID: 7910130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged paralysis after treatment with neuromuscular junction blocking agents.
    Gooch JL; Suchyta MR; Balbierz JM; Petajan JH; Clemmer TP
    Crit Care Med; 1991 Sep; 19(9):1125-31. PubMed ID: 1679384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological characteristics of the inhibition of nondepolarizing neuromuscular blocking agents at human adult muscle nicotinic acetylcholine receptor.
    Jonsson Fagerlund M; Dabrowski M; Eriksson LI
    Anesthesiology; 2009 Jun; 110(6):1244-52. PubMed ID: 19417616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prolonged paralysis after administration of pancuronium bromide].
    Salehi E
    Z Prakt Anasth Wiederbeleb Intensivther; 1972 Aug; 7(4):207-11. PubMed ID: 4269040
    [No Abstract]   [Full Text] [Related]  

  • 26. Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment.
    Danon MJ; Carpenter S
    Muscle Nerve; 1991 Nov; 14(11):1131-9. PubMed ID: 1684024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-resistance to both atracurium- and vecuronium-induced neuromuscular blockade in a critically ill patient.
    Fish DN; Singletary TJ
    Pharmacotherapy; 1997; 17(6):1322-7. PubMed ID: 9399619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postoperative residual paralysis and respiratory status: a comparative study of pancuronium and vecuronium.
    Bissinger U; Schimek F; Lenz G
    Physiol Res; 2000; 49(4):455-62. PubMed ID: 11072806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pharmacoeconomic analysis of neuromuscular blocking agents in the operating room.
    Loughlin KA; Weingarten CM; Nagelhout J; Stevenson JG
    Pharmacotherapy; 1996; 16(5):942-50. PubMed ID: 8888091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should ICU patients receive muscle relaxants?
    Coakley J
    Schweiz Med Wochenschr; 1996 Sep; 126(39):1644-8. PubMed ID: 8858758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Critical illness neuropathies].
    Magistris MR
    Rev Neurol (Paris); 2002 Mar; 158(3):293-9. PubMed ID: 11976588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brief review: Nondepolarizing neuromuscular blocking drugs and critical illness myopathy.
    Murray MJ; Brull SJ; Bolton CF
    Can J Anaesth; 2006 Nov; 53(11):1148-56. PubMed ID: 17079642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prolonged neuromuscular block after a single dose of vecuronium in a patient with undiagnosed polyneuropathy and steroid myopathy].
    Rama-Maceiras P; Pensado A; Aymerich H; Molins N; Ferreira TA; Vázquez-Fidalgo A
    Rev Esp Anestesiol Reanim; 1999 Jan; 46(1):37-9. PubMed ID: 10073081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged neuromuscular blockade in a horse following concomitant use of vecuronium and atracurium.
    Gurney M; Mosing M
    Vet Anaesth Analg; 2012 Jan; 39(1):119-20. PubMed ID: 22118190
    [No Abstract]   [Full Text] [Related]  

  • 35. Sedation after intubation using etomidate and a long-acting neuromuscular blocker.
    Kendrick DB; Monroe KW; Bernard DW; Tofil NM
    Pediatr Emerg Care; 2009 Jun; 25(6):393-6. PubMed ID: 19458564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical approach to the weak patient in the intensive care unit.
    Dhand UK
    Respir Care; 2006 Sep; 51(9):1024-40; discussion 1040-1. PubMed ID: 16934166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potentiation of atracurium by pancuronium during propofol-fentanyl-N2O anesthesia.
    Nathan N; Bonada G; Feiss P
    Acta Anaesthesiol Belg; 1996; 47(4):187-93. PubMed ID: 9093646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Residual paralysis following a single dose of atracurium: results from a quality assurance trial.
    Schreiber JU; Mucha E; Fuchs-Buder T
    Eur J Anaesthesiol; 2010 Nov; 27(11):993-4. PubMed ID: 20485177
    [No Abstract]   [Full Text] [Related]  

  • 39. [Acute myopathy during treatment of status asthmaticus].
    op de Coul AA; Verheul GA; Timmerhuis TP; Teepen JL
    Ned Tijdschr Geneeskd; 1996 Feb; 140(5):268-71. PubMed ID: 8643135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EMG findings in acute myopathy with status asthmaticus, steroids and paralytics. Clinical and electrophysiologic correlation.
    David WS; Roehr CL; Leatherman JW
    Electromyogr Clin Neurophysiol; 1998 Sep; 38(6):371-6. PubMed ID: 9783124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.